Plain-English translation of NCT07757334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new group therapy approach for people who have experienced trauma and are now experiencing lasting symptoms like anxiety, stress, or emotional difficulty. The therapy combines proven techniques from two established treatments—Eye Movement Desensitization and Reprocessing (EMDR) and Sensorimotor Psychotherapy—and is delivered as group sessions within your regular primary care setting. Half of participants will receive this new trauma-focused therapy right away, while the other half will receive their usual care and then be offered the therapy later.
Trauma-related disorders are common but often go unrecognized in primary care clinics, and many people never receive evidence-based treatment because it's hard to access or implement in routine healthcare settings. This trial aims to test whether offering this treatment in a group format through primary care makes it more accessible, more affordable to provide, and just as effective for helping people heal from trauma.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either start the trauma-focused group therapy right away or receive your usual care first. Either way, you'll have clinical assessments at the beginning, after the therapy ends, and at a follow-up visit to measure how you're doing. The group therapy itself is delivered through your primary care setting and includes sessions focused on stabilizing your emotions, processing traumatic memories, and integrating what you've learned—all within a supportive group environment.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Spain